img
Home Tags Checkpoint Inhibitors

Tag: Checkpoint Inhibitors

Neutrophil Defensin Expression Correlated With Immune Checkpoint Response In Lung Cancer

Lung cancer is the leading cause of cancer related death. Non-small cell lung cancer (NSCLC), comprises 80–85% of all lung cancer cases. Programmed cell death ligand 1 (PDL1) is an approved immunotherapeutic target in lung cancer patients. PDL1 expression...

CLOVER Study Of PDL1 In NSCLC Demonstrates PCR RNA Expression Analysis Not Equivalent To...

Programmed cell death ligand 1 (PDL1) is approved therapeutic target in lung cancer patients. PDL1 expression above a set threshold must be confirmed by companion immunohistochemistry (IHC) test in order for the patient to be eligible for PDL1 checkpoint...

⭐ Recently Featured

🔥 Popular Posts

X